PMGC (NASDAQ:ELAB) Stock Price Down 11.1% – Here’s What Happened

PMGC Holdings Inc. (NASDAQ:ELAB)’s stock price fell 11.1% during trading on Tuesday . The stock traded as low as $4.07 and last traded at $4.39. 294,220 shares changed hands during mid-day trading, an increase of 20% from the average session volume of 244,312 shares. The stock had previously closed at $4.94.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on ELAB shares. Wall Street Zen raised shares of PMGC to a “sell” rating in a research note on Saturday, October 25th. Weiss Ratings restated a “sell (e)” rating on shares of PMGC in a report on Monday, December 1st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, PMGC has an average rating of “Sell”.

PMGC Trading Down 11.1%

The stock’s fifty day moving average price is $5.70 and its 200 day moving average price is $6.47. The stock has a market cap of $2.99 million, a P/E ratio of -0.26 and a beta of 0.29.

PMGC (NASDAQ:ELAB) last issued its quarterly earnings results on Friday, November 14th. The company reported ($4.95) earnings per share (EPS) for the quarter. The company had revenue of $0.29 million for the quarter.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.